In the Press

Global experts pan wider use of COVID vaccine booster dose

An international group of vaccine experts, including two former US Food and Drug Administration (FDA) officials, said today that scientific evidence doesn't yet support the broader rollout of COVID-19 boosters.


Everything you need to know about chemical exposure

Chemicals hazards are in every workplace – even at home


Chest radiography or computed tomography for COVID-19 pneumonia? Comparative study in a simulated triage setting

This study does not support the routine use of CT to stage disease extent in COVID-19 pneumonia, despite superior interobserver agreement, as chest radiography extent is an equally powerful prognostic determinant


Effects of Asian dust storm events on daily stroke admissions in Taipei, Taiwan

In spring, windblown dust storms originating in the deserts of Mongolia and China make their way to Taipei city.


Consuming Sucrose- or HFCS-sweetened Beverages Increases Hepatic Lipid and Decreases Insulin Sensitivity in Adults

Over the past decade the prevalence of both nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2D) have dramatically increased worldwide, establishing both as global health concerns (1, 2).


Researchers identify a novel player in acute myeloid leukemia

A new study led by scientists at Sanford Burnham Prebys has shown that the protein RNF5 plays an unusual role in acute myeloid leukemia (AML). Unlike its expected role, marking aberrant proteins for destruction, RNF5 binds with a second cell protein called RBBP4 to control expression of genes implicated in AML. These findings, published in Nature Communications, have important implications for improving AML patient outcomes.


In the hunt for novel antibiotics, will new technology overtake underwater exploration?

Chemist Brian Murphy, pictured in the Molecular Biology Research Building at the University of Illinois Chicago, searches for novel antibiotics by diving for freshwater sponge microbes.


First responders haunted by 9/11 terrorism for 20 years to be treated with minute doses of electricity

Twenty years after the 9/11 terror attacks on the United States, survivors still suffer from posttraumatic stress disorder—PTSD—a condition that New York researchers will attempt to control through bioelectronic medicine, delivered as imperceptible pulses of electricity from "ear buds" in patients' ears.


none 08:00 AM - 05:00 PM 08:00 AM - 05:00 PM 08:00 AM - 05:00 PM 08:00 AM - 05:00 PM 08:00 AM - 05:00 PM 08:00 AM - 05:00 PM 08:00 AM - 05:00 PM others https://g.page/r/CcoVFDGYiftXEAg/review https://www.facebook.com/Healthy-Builds-West-Palm-106299645058480/reviews/?ref=page_internal